These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 19666154

  • 1. Prevention of otitis media: now a reality?
    Schuerman L, Borys D, Hoet B, Forsgren A, Prymula R.
    Vaccine; 2009 Sep 25; 27(42):5748-54. PubMed ID: 19666154
    [Abstract] [Full Text] [Related]

  • 2. 10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix.
    Prymula R, Schuerman L.
    Expert Rev Vaccines; 2009 Nov 25; 8(11):1479-500. PubMed ID: 19863240
    [Abstract] [Full Text] [Related]

  • 3. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
    Vesikari T, Wysocki J, Chevallier B, Karvonen A, Czajka H, Arsène JP, Lommel P, Dieussaert I, Schuerman L.
    Pediatr Infect Dis J; 2009 Apr 25; 28(4 Suppl):S66-76. PubMed ID: 19325449
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
    Knuf M, Szenborn L, Moro M, Petit C, Bermal N, Bernard L, Dieussaert I, Schuerman L.
    Pediatr Infect Dis J; 2009 Apr 25; 28(4 Suppl):S97-S108. PubMed ID: 19325452
    [Abstract] [Full Text] [Related]

  • 5. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J, Tejedor JC, Grunert D, Konior R, Garcia-Sicilia J, Knuf M, Bernard L, Dieussaert I, Schuerman L.
    Pediatr Infect Dis J; 2009 Apr 25; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [Abstract] [Full Text] [Related]

  • 6. The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity.
    Bermal N, Szenborn L, Chrobot A, Alberto E, Lommel P, Gatchalian S, Dieussaert I, Schuerman L.
    Pediatr Infect Dis J; 2009 Apr 25; 28(4 Suppl):S89-96. PubMed ID: 19325451
    [Abstract] [Full Text] [Related]

  • 7. Pneumococcal conjugated vaccine: PHiD-CV.
    Dinleyici EC, Yargic ZA.
    Expert Rev Anti Infect Ther; 2009 Nov 25; 7(9):1063-74. PubMed ID: 19883326
    [Abstract] [Full Text] [Related]

  • 8. Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.
    Chevallier B, Vesikari T, Brzostek J, Knuf M, Bermal N, Aristegui J, Borys D, Cleerbout J, Lommel P, Schuerman L.
    Pediatr Infect Dis J; 2009 Apr 25; 28(4 Suppl):S109-18. PubMed ID: 19325447
    [Abstract] [Full Text] [Related]

  • 9. Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines.
    Forsgren A, Riesbeck K, Janson H.
    Clin Infect Dis; 2008 Mar 01; 46(5):726-31. PubMed ID: 18230042
    [Abstract] [Full Text] [Related]

  • 10. Immunogenicity, reactogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Mexican infants.
    Ruiz-Palacios GM, Guerrero ML, Hernández-Delgado L, Lavalle-Villalobos A, Casas-Muñoz A, Cervantes-Apolinar Y, Moreira M, Schuerman L.
    Hum Vaccin; 2011 Nov 01; 7(11):1137-45. PubMed ID: 22048109
    [Abstract] [Full Text] [Related]

  • 11. Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage.
    Clarke C, Bakaletz LO, Ruiz-Guiñazú J, Borys D, Mrkvan T.
    Expert Rev Vaccines; 2017 Jul 01; 16(7):1-14. PubMed ID: 28571504
    [Abstract] [Full Text] [Related]

  • 12. Clinical characteristics of a novel 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine candidate (PHiD-CV). Introduction.
    Dagan R, Frasch C.
    Pediatr Infect Dis J; 2009 Apr 01; 28(4 Suppl):S63-5. PubMed ID: 19325448
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trial.
    Sáez-Llorens X, Rowley S, Wong D, Rodríguez M, Calvo A, Troitiño M, Salas A, Vega V, Castrejón MM, Lommel P, Pascal TG, Hausdorff WP, Borys D, Ruiz-Guiñazú J, Ortega-Barría E, Yarzabal JP, Schuerman L.
    Hum Vaccin Immunother; 2017 Jun 03; 13(6):1-16. PubMed ID: 28368738
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial.
    Tregnaghi MW, Sáez-Llorens X, López P, Abate H, Smith E, Pósleman A, Calvo A, Wong D, Cortes-Barbosa C, Ceballos A, Tregnaghi M, Sierra A, Rodriguez M, Troitiño M, Carabajal C, Falaschi A, Leandro A, Castrejón MM, Lepetic A, Lommel P, Hausdorff WP, Borys D, Ruiz Guiñazú J, Ortega-Barría E, Yarzábal JP, Schuerman L, COMPAS Group.
    PLoS Med; 2014 Jun 03; 11(6):e1001657. PubMed ID: 24892763
    [Abstract] [Full Text] [Related]

  • 15. 10-Valent pneumococcal non-typeable haemophilus influenzae protein D-conjugate vaccine: a review in infants and children.
    Plosker GL.
    Paediatr Drugs; 2014 Oct 03; 16(5):425-44. PubMed ID: 25192686
    [Abstract] [Full Text] [Related]

  • 16. Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV).
    Croxtall JD, Keating GM.
    Paediatr Drugs; 2009 Oct 03; 11(5):349-57. PubMed ID: 19725600
    [Abstract] [Full Text] [Related]

  • 17. Passive immunization with human anti-protein D antibodies induced by polysaccharide protein D conjugates protects chinchillas against otitis media after intranasal challenge with Haemophilus influenzae.
    Novotny LA, Jurcisek JA, Godfroid F, Poolman JT, Denoël PA, Bakaletz LO.
    Vaccine; 2006 May 29; 24(22):4804-11. PubMed ID: 16616975
    [Abstract] [Full Text] [Related]

  • 18. Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation model.
    De Wals P, Black S, Borrow R, Pearce D.
    Clin Ther; 2009 Oct 29; 31(10):2152-69. PubMed ID: 19922887
    [Abstract] [Full Text] [Related]

  • 19. Immunogenicity, safety and reactogenicity of the 10-valent pneumococcal non-typeable haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian Infants: a randomised trial.
    Odusanya OO, Kuyinu YA, Kehinde OA, Francois N, Yarzabal JP, Moreira M, Borys D, Schuerman L.
    Niger Postgrad Med J; 2013 Dec 29; 20(4):272-81. PubMed ID: 24633268
    [Abstract] [Full Text] [Related]

  • 20. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study.
    Prymula R, Peeters P, Chrobok V, Kriz P, Novakova E, Kaliskova E, Kohl I, Lommel P, Poolman J, Prieels JP, Schuerman L.
    Lancet; 2006 Mar 04; 367(9512):740-8. PubMed ID: 16517274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.